Alert: Because flu cases are on the rise, children 12 and younger will be restricted from visiting hospitals and certain inpatient facilities. Learn more.

Research and Clinical Trials

Brief Description  
This study is a placebo-controlled randomized, double-blind study to compare overall survival of subjects with locally-advanced pancreatic cancer.
Who may be Eligible  

  • Histologic or cytologic documentation of adenocarcinoma of the pancreas
  • Unresectable disease due to local extension or invasion, for example:
    • Tumor extension precluding resection, eg, to mesenteric or retroperitoneal structures, vascular encasement, etc, or
    • Lymph node involvement beyond the surgical field
  • Recovery from toxicity of previous procedures that establish diagnosis of locally-advanced disease (patients with previous pancreatic resection are excluded)
  • ECOG PS 0 or 1
IRB Number  
Principal Investigator  
Salmon, Stuart

For More Information, Contact  Delois  , DeShazo
Phone:  (704) 355-1342  Fax:  (704) 355-1353  
Email:  Delois.DeShazo@carolinashealthcare.org
Address:1100 South Tryon Street Suite 220 Charlotte, NC 28203